• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉血栓形成与骨折风险增加相关。

Portal vein thrombosis is associated with an increased risk of bone fractures.

机构信息

Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

Cirrhosis Center Mainz (CCM), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.

出版信息

PLoS One. 2022 Apr 22;17(4):e0267535. doi: 10.1371/journal.pone.0267535. eCollection 2022.

DOI:10.1371/journal.pone.0267535
PMID:35452487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032344/
Abstract

BACKGROUND

Portal vein thrombosis (PVT) is a rare but severe disease that often leads to portal hypertension-related complications. It is well-known that patients with portal hypertension associated with liver cirrhosis are at increased risk for bone fractures, however data on the impact of PVT on fracture risk are lacking.

AIMS

This study aimed to explore the impact of PVT on the incidence of bone fractures in a large German primary care cohort.

METHODS

Patients with PVT were extensively matched to non-PVT individuals in a 1:5 ratio. The primary outcome of the study was the incidence of any bone fracture.

RESULTS

This study included 596 patients with PVT and 2,980 non-PVT individuals. During five years of follow-up, the cumulative incidence of bone fractures was significantly higher in PVT patients (n = 87, 13.6%) than in those without PVT (n = 186, 6.7%) (p<0.001). In Cox-regression analyses, PVT was positively associated with bone fractures (HR: 2.16; 95% CI: 1.59-2.93). This association was stronger in women (HR: 2.55; 95% CI: 1.65-3.95) than in men (HR: 1.87; 95% CI: 1.22-2.87). The strongest association was observed in the age group 51-60 years (HR: 2.50, 95% CI: 1.40-4.47). The association between PVT and bone fractures was maintained in subgroup analyses of patients with (HR: 2.03, 95% CI: 1.13-3.63) and without liver cirrhosis (HR: 1.82, 95% CI: 1.28-2.58).

CONCLUSIONS

PVT is independently associated with a higher incidence of bone fractures. Patients with PVT should be critically evaluated for fracture risk and preventive measures should be considered.

摘要

背景

门静脉血栓形成(PVT)是一种罕见但严重的疾病,常导致门静脉高压相关并发症。众所周知,伴有肝硬化的门静脉高压患者发生骨折的风险增加,然而,关于 PVT 对骨折风险影响的数据尚缺乏。

目的

本研究旨在探讨 PVT 在德国大型初级保健队列中对骨折发生率的影响。

方法

将 PVT 患者与非 PVT 患者进行 1:5 比例的广泛匹配。本研究的主要结局是任何骨折的发生率。

结果

本研究纳入了 596 例 PVT 患者和 2980 例非 PVT 个体。在 5 年的随访期间,PVT 患者(n=87,13.6%)骨折的累积发生率明显高于非 PVT 患者(n=186,6.7%)(p<0.001)。在 Cox 回归分析中,PVT 与骨折呈正相关(HR:2.16;95%CI:1.59-2.93)。这种相关性在女性中更强(HR:2.55;95%CI:1.65-3.95),而在男性中则较弱(HR:1.87;95%CI:1.22-2.87)。最强的相关性发生在 51-60 岁年龄组(HR:2.50,95%CI:1.40-4.47)。在伴有(HR:2.03,95%CI:1.13-3.63)和不伴有肝硬化(HR:1.82,95%CI:1.28-2.58)的患者亚组分析中,PVT 与骨折之间的相关性仍然存在。

结论

PVT 与骨折发生率升高独立相关。应仔细评估 PVT 患者的骨折风险,并考虑采取预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/54bd9dd7844d/pone.0267535.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/200d1562fffe/pone.0267535.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/0028b826c604/pone.0267535.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/54bd9dd7844d/pone.0267535.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/200d1562fffe/pone.0267535.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/0028b826c604/pone.0267535.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/9032344/54bd9dd7844d/pone.0267535.g003.jpg

相似文献

1
Portal vein thrombosis is associated with an increased risk of bone fractures.门静脉血栓形成与骨折风险增加相关。
PLoS One. 2022 Apr 22;17(4):e0267535. doi: 10.1371/journal.pone.0267535. eCollection 2022.
2
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.肝硬化门静脉血栓形成的相关危险因素:一项病例对照研究。
Ter Arkh. 2019 Mar 18;91(2):73-81. doi: 10.26442/00403660.2019.02.000153.
3
Statin use in cirrhosis and its association with incidence of portal vein thrombosis.他汀类药物在肝硬化中的应用及其与门静脉血栓形成发生率的关联。
J Gastroenterol Hepatol. 2024 May;39(5):955-963. doi: 10.1111/jgh.16495. Epub 2024 Jan 25.
4
Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.肝硬化和门静脉血栓形成患者抗凝剂的有害和有益作用。
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1146-1152.e4. doi: 10.1016/j.cgh.2017.10.016. Epub 2017 Oct 21.
5
Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis.代谢相关脂肪性肝病相关肝硬化及门静脉血栓形成的发生率。
Eur J Gastroenterol Hepatol. 2024 Aug 1;36(8):1038-1045. doi: 10.1097/MEG.0000000000002800. Epub 2024 May 30.
6
Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.肝硬化门静脉血栓形成的发生率、预测因素及临床意义:一项前瞻性研究。
Liver Int. 2019 Aug;39(8):1459-1467. doi: 10.1111/liv.14121. Epub 2019 May 15.
7
[Clinical features and risk factors of portal vein thrombosis in 28 patients with antiphospholipid syndrome].[28例抗磷脂综合征患者门静脉血栓形成的临床特征及危险因素]
Zhonghua Nei Ke Za Zhi. 2019 Dec 1;58(12):894-898. doi: 10.3760/cma.j.issn.0578-1426.2019.12.005.
8
A high rate of post thrombotic complication in pediatric portal vein thrombosis.小儿门静脉血栓形成后血栓后并发症发生率高。
Thromb Res. 2023 Nov;231:44-49. doi: 10.1016/j.thromres.2023.09.015. Epub 2023 Sep 30.
9
A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors.一项关于肝硬化患者门静脉血栓形成的单中心医院研究——临床特征与危险因素。
Indian J Med Res. 2014 Feb;139(2):260-6.
10
Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.对血栓调节蛋白的抵抗与肝硬化患者的新发门静脉血栓形成及低生存率相关。
Liver Int. 2016 Sep;36(9):1322-30. doi: 10.1111/liv.13087. Epub 2016 Mar 31.

本文引用的文献

1
Falls are common, morbid, and predictable in patients with cirrhosis.肝硬化患者常发生、可导致发病和可预测的是跌倒。
J Hepatol. 2021 Sep;75(3):582-588. doi: 10.1016/j.jhep.2021.04.012. Epub 2021 Apr 19.
2
Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.非肝硬化性门静脉高压症的综合治疗:基于病例报告的讨论。
Z Gastroenterol. 2021 Jan;59(1):43-49. doi: 10.1055/a-1330-9827. Epub 2021 Jan 11.
3
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.
肝病患者的血管性肝脏疾病、门静脉血栓形成及操作出血:美国肝病研究协会2020年实践指南
Hepatology. 2021 Jan;73(1):366-413. doi: 10.1002/hep.31646. Epub 2021 Jan 20.
4
Causes and Management of Non-cirrhotic Portal Hypertension​.非肝硬化性门静脉高压的病因和处理。
Curr Gastroenterol Rep. 2020 Sep 17;22(12):56. doi: 10.1007/s11894-020-00792-0.
5
Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension.非肝硬化性门静脉高压症中肌少症的患病率和影响。
Liver Int. 2019 Oct;39(10):1937-1942. doi: 10.1111/liv.14160. Epub 2019 Jun 26.
6
Noncirrhotic nontumoral portal vein thrombosis.非肝硬化非肿瘤性门静脉血栓形成
Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):118-121. doi: 10.1002/cld.336. eCollection 2014 Jun.
7
Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort.全国代表性住院患者队列中肝硬化门静脉血栓形成的患病率及其相关死亡率。
J Gastroenterol Hepatol. 2019 Jun;34(6):1088-1092. doi: 10.1111/jgh.14501. Epub 2018 Nov 4.
8
Basic characteristics and representativeness of the German Disease Analyzer database
.德国疾病分析器数据库的基本特征及代表性
Int J Clin Pharmacol Ther. 2018 Oct;56(10):459-466. doi: 10.5414/CP203320.
9
The association between liver cirrhosis and fracture risk: A systematic review and meta-analysis.肝硬化与骨折风险的相关性:系统评价和荟萃分析。
Clin Endocrinol (Oxf). 2018 Oct;89(4):408-413. doi: 10.1111/cen.13762. Epub 2018 Aug 9.
10
Hip fracture risk in patients with alcoholic cirrhosis: A population-based study using English and Danish data.患有酒精性肝硬化患者的髋部骨折风险:一项基于英国和丹麦数据的人群研究。
J Hepatol. 2018 Sep;69(3):697-704. doi: 10.1016/j.jhep.2018.04.002. Epub 2018 Apr 17.